Evidence map›Paper›PMID 22687231›Full record

Trial reportThe British journal of general practice : the journal of the Royal College of General Practitioners2012

Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort.

Morten Charles, Rebecca K Simmons, Kate M Williams, Gojka Roglic, Stephen J Sharp, Ann-Louise Kinmonth, Nicholas J Wareham, Simon J Griffin

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The British journal of general practice : the journal of the Royal College of General Practitioners, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014
    Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Morten CharlesSection of General Practice, Department of Public Health, Faculty of Health Sciences, Aarhus University, Denmark.
Rebecca K Simmons
Kate M Williams
Gojka Roglic
Stephen J Sharp
Ann-Louise Kinmonth
Nicholas J Wareham
Simon J Griffin
Aarhus University · DKWorld Health Organization · CH

Funding

Department of Health RP-PG-0606-1259Medical Research Council G0001164Medical Research Council G0200391Medical Research Council MC_U106179471Medical Research Council MC_U106179474Wellcome Trust G061895
6 · The paper itself

Abstract

backgroundUncertainties persist concerning the effects of early intensive management of type 2 diabetes and which patients benefit most from such an approach.

aimTo describe change in modelled cardiovascular risk in the 14 months following diagnosis, and to examine which baseline patient characteristics and treatment components are associated with risk reduction. DESIGN AND

settingA cohort of individuals from a pragmatic, single-blind, cluster-randomised controlled trial of 236 females and 361 males with screen-detected type 2 diabetes and without prior cardiovascular disease (CVD), from 49 GP surgeries in eastern England, examined at baseline (2002-2006) and after 14-months' follow-up.

methodMultiple linear regression was used to quantify the association between baseline patient characteristics, treatment components, and change in modelled 10-year cardiovascular risk (UK Prospective Diabetes Study [UKPDS] [version 3] risk engine).

resultsThere was a downward shift in the distribution of modelled CVD risk over 14 months mean 31% (standard deviation [SD] = 14%) to 26% [SD = 13%]). Older individuals, males, and those with a larger waist circumference at baseline exhibited smaller risk reductions. Individuals prescribed higher numbers of drugs over the follow-up period, and those who decreased their energy intake or reduced their weight, demonstrated larger reductions in modelled risk.

conclusionIt is possible to achieve significant reductions in modelled CVD risk over 14 months following diagnosis of diabetes by screening. Risk reduction appeared to be driven mainly by prescription of higher numbers of drugs, decreased energy intake, and weight reduction. There was room for further risk reduction, as many patients were not prescribed recommended treatments.

Indexed as

AgedAntihypertensive AgentsBody Mass IndexCluster AnalysisDiabetes Mellitus, Type 2Diabetic AngiopathiesEarly DiagnosisFemaleFollow-Up StudiesGlycated HemoglobinHealth PromotionHumansHypercholesterolemiaHypertensionHypoglycemic AgentsHypolipidemic AgentsAntihypertensive AgentsGlycated HemoglobinHypoglycemic AgentsHypolipidemic Agents

Identifiers

PMID22687231
PMCPMC3361118
OpenAlexW2088043984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.